NCG · Class II · 21 CFR 882.1440

FDA Product Code NCG: Neuropsychiatric Interpretative Electroencephalograph Assessment Aid

Uses A Patient's Electroencephalograph (eeg) To Provide An Interpretation Of The Patient's Neuropsychiatric Condition. It Is Also Used Only As An Assessment Aid For A Medical Condition For Which There Exists Other Valid Methods Of Diagnosis."

Leading manufacturers include Ceribell, Inc. and Prolira B.V..

3
Total
2
Cleared
300d
Avg days
2013
Since
Stable submission activity - 1 submissions in the last 2 years
Review times improving: avg 167d recently vs 367d historically

FDA 510(k) Cleared Neuropsychiatric Interpretative Electroencephalograph Assessment Aid Devices (Product Code NCG)

3 devices
1–3 of 3

About Product Code NCG - Regulatory Context

510(k) Submission Activity

3 total 510(k) submissions under product code NCG since 2013, with 2 receiving FDA clearance (average review time: 300 days).

Submission volume has remained relatively stable over the observed period, with 1 submissions in the last 24 months.

FDA Review Time

Recent submissions under NCG have taken an average of 167 days to reach a decision - down from 367 days historically, suggesting improved FDA processing for this classification.

NCG devices are reviewed by the Neurology panel. Browse all Neurology devices →